Research guide
Research Peptides vs Compounded Peptides: What's the Difference?
Quick answers
- What is a research peptide?
- A chemical sold for laboratory research, labeled "research use only." It is not a drug, is not approved for people, and is not for human consumption.
- What is a compounded peptide?
- A medication prepared by a licensed pharmacy or outsourcing facility, usually on a prescription. It is not FDA-approved, but it is made inside a regulated pharmacy system.
- Who can dispense each?
- Compounded drugs go through licensed pharmacists and prescribers. Research chemicals are sold to researchers and are not dispensed to patients at all.
- What do 503A, 503B and USP mean?
- 503A covers traditional pharmacies compounding for individual patients. 503B covers FDA-registered outsourcing facilities that follow manufacturing rules. USP sets the written standards pharmacies follow for compounding.
- Can a research peptide be "compounded" by buying it online?
- No. Calling a research chemical "compounded" does not make it one. The difference is the legal and quality system behind it, not the molecule.
People often treat these two terms as if they were the same thing at different prices. They are not. The same peptide sequence can exist as a research chemical, as a compounded medication, or as an approved drug. What separates them is the system it was made and sold under: who made it, who checked it, and who is legally allowed to hand it to whom.
This page explains those differences in plain words. It is not medical advice. Research peptides are for research use only and are not for human consumption.
Research peptides
A research peptide is a chemical sold to laboratories and researchers for experiments. It carries a "research use only" (RUO) or "not for human consumption" label. That label means the product has not gone through the process needed to be marketed for diagnosing or treating anyone.
- Legal status: sold as a laboratory chemical, not a drug.
- Who makes it: chemical manufacturers and resellers. There is no required license specific to research peptides.
- Quality oversight: whatever the seller chooses to do. There is no required testing standard, no routine inspection, and no required sterility. Quality depends entirely on the supplier, which is why lot-matched COAs matter so much.
- Who can receive it: it is sold for research. It is not dispensed to patients.
For more on the label itself, see What Are Research Peptides? and What Does "Research Use Only" Actually Mean?
Compounded peptides
Compounding is a pharmacy practice. The FDA describes it as combining, mixing or altering ingredients to make a medication suited to an individual patient. Compounded drugs are not FDA-approved. The FDA does not check their safety, effectiveness or quality before they are sold. But they are made inside a licensed, inspected system with written standards.
The 2013 Drug Quality and Security Act set up two lanes. We cover the background in What Is a Compounded Drug?
503A: traditional pharmacies
- A state-licensed pharmacy or physician compounds a drug for a specific patient, based on a prescription.
- Oversight is mainly by state boards of pharmacy.
- The pharmacy is expected to follow USP compounding standards.
- There are limits on which bulk ingredients can be used. In general, an ingredient must have a USP or National Formulary monograph, be part of an FDA-approved drug, or appear on an FDA list of allowed bulk substances.
503B: outsourcing facilities
- A facility registers with the FDA as an outsourcing facility.
- It can make larger batches, sometimes without a patient-specific prescription, for example for hospitals and clinics.
- It must follow federal current good manufacturing practice (CGMP) and is subject to FDA inspection.
USP, in plain words
USP is the United States Pharmacopeia, an organization that writes quality standards for medicines. For compounding, two chapters come up most. USP <795> covers non-sterile compounding, like creams and capsules. USP <797> covers sterile compounding, which includes anything meant to be injected. These chapters set rules for clean rooms, garbing, testing and beyond-use dates. A research chemical seller is not held to them.
Side by side
| Research peptide | Compounded peptide | |
|---|---|---|
| Intended for people? | No. Research only. | Yes, for a prescribed patient. |
| FDA-approved? | No | No |
| Who prepares it? | Chemical supplier | Licensed pharmacy (503A) or FDA-registered facility (503B) |
| Written quality standard? | None required | USP chapters (503A); CGMP (503B) |
| Inspection? | None required | State boards (503A); FDA (503B) |
| Sterility required? | No | Yes, for sterile preparations |
| Prescription? | Not applicable | Usually required (503A) |
Not every peptide can be compounded
Being a peptide does not make a molecule eligible for compounding. The FDA has reviewed several peptides that were being nominated for use as bulk compounding ingredients and raised safety concerns about some of them. In 2023 it flagged substances including BPC-157 as possibly presenting significant safety risks in compounding, citing concerns such as impurities and limited human safety data. These lists are revisited over time, so check the FDA's current compounding pages for the status of a specific substance.
Investigational drugs like retatrutide are a separate case again. They exist inside clinical trials run by their developer. They are not approved, and they are not legal to compound as copies of an approved product, because there is no approved product.
Why RUO products are not for human use
The RUO label is not a technicality. It reflects real gaps. There is no required sterility testing, no required endotoxin limit, no required check that the vial holds what the label says, and no one inspecting the facility. A compounding pharmacy that skipped those steps would be breaking the rules. A research chemical seller is not held to them in the first place.
That is why the right question is not "which is cheaper?" It is "which system was this made under, and what checks did it pass?" For research use, a careful buyer still asks for lot-matched testing. See How to Tell If a Research Peptide Company Is Legit.
Questions about any medication for a person belong with a physician and a licensed pharmacist.
Sources
- U.S. Food and Drug Administration. Human Drug Compounding. Source
Peptide Proof reports what studies found. Research peptides are for research use only and are not for human consumption. Nothing on this page is medical advice, dosing guidance or a treatment recommendation.
Where to buy: researchers who want materials with a certificate of analysis can see our sourcing partner, Trynx Research.
Get the evidence, not the hype.
New research briefs, plainly written and fully sourced. No dosing advice, ever.